RARE - Ultragenyx Pharmaceutical prices $350 million securities offering
2024-06-14 04:45:04 ET
More on Ultragenyx Pharmaceutical
- Ultragenyx: Modest Sales Growth, With Multiple Inflection Points Approaching
- Ultragenyx to file for accelerated approval of rare metabolic disease candidate
- Mereo spikes after mid-stage data for Ultragenyx-partnered bone disorder therapy
- Seeking Alpha’s Quant Rating on Ultragenyx Pharmaceutical